Martin Welschof

Martin Welschof was the founder of Affitech AS, founded in 1997, and Affitech A, founded in 2003, where the title of Chief Executive Officer was held from 2003 to 2009.
Current jobs include Chief Executive Officer at BioInvent International AB since 2018, Director at Anocca AB, Director at Uni Targeting Research AS since 2007, Director at Nextera AS since 2013, and Director at APIM Therapeutics AS since 2015.
Former jobs include Chief Executive Officer at Opsona Therapeutics Ltd. from 2012 to 2018, Technology Director at Axaron Bioscience AG from 1997 to 2002, Director at ExpreS2ion Biotechnologies ApS, Director at Zelluna Immunotherapy AS, and Principal at Lynx Therapeutics, Inc. Education includes a doctorate from the University of Bielefeld, conferred in 1996.